Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
11/2008
11/12/2008EP1989206A2 Inhibitors of e1 activating enzyme
11/12/2008EP1989205A2 Thiophene-carboxamides useful as inhibitors of protein kinases
11/12/2008EP1989204A1 Pyrazoloquinolones are potent parp inhibitors
11/12/2008EP1989203A2 Alpha carbolines and uses thereof
11/12/2008EP1989201A1 Pi-3 kinase inhibitors and methods of their use
11/12/2008EP1988892A2 Modulators of muscarinic receptors
11/12/2008EP1888577B1 Ocaperidone salts and pharmaceutical compositions containing the same
11/12/2008EP1680422B1 Bispidon-derivated ligands and complex for catalytically bleaching a substrate
11/12/2008EP1628977B1 ANTIBIOTIC TETRAHYDRO-b-CARBOLINE DERIVATIVES
11/12/2008EP1549648B1 Bicyclic heteroaromatic compounds as kinase inhibitors
11/12/2008EP1409468B1 Guanidinobenzamides as mc4-r agonists
11/12/2008EP1315490B1 A method for treating allergies using substituted pyrazoles
11/12/2008EP1261607B1 2,4-disubstituted thiazolyl derivatives
11/12/2008CN101305005A Novel diazaspiroalkanes and their use for treatment of CCR8 mediated diseases
11/12/2008CN101305004A Novel diazabicyclic aryl derivatives and their medical use
11/12/2008CN101305003A (1-aza-bicyclo[3.3.1] n0n-4-yl)-[5-(1H-indol-5-yl)-heteroaryl]-amines as cholinergic ligands of the n-ACHR for the treatment of psychotic and neurodegenerative disorders
11/12/2008CN101305002A Methods of modulating neurotrophin-mediated activity
11/12/2008CN101305001A Indolizine derivatives as ligands of the CRTH2 receptor
11/12/2008CN101305000A 5-oxo-5,8-dihydro-pyrido-pyrimidines as inhibitors of C-FMS kinase
11/12/2008CN101304999A Non-steroidal compounds useful as glucocorticoid receptor modulators
11/12/2008CN101304998A 7-substituted aza-indazoles, compositions containing same, production method and use thereof
11/12/2008CN101302227A Method for synthesizing 3,3í»-purrocoline compounds
11/12/2008CN101302217A Triazole compounds, preparation and use thereof
11/12/2008CN101302216A Preparation of condensed ring indole compounds
11/12/2008CN101302182A Virus polymerase inhibitors
11/12/2008CN100432075C Diazabicyclic aryl derivatives as nicotinic acetylcholine receptor ligands
11/12/2008CN100432073C 6-alkoxy-pyrido-pyrimidines as p-38 MAP kinase inhibitors
11/12/2008CN100432055C Tricyclic protein kinase inhibitors
11/11/2008US7450293 Electrochromic salts, solutions, and devices
11/11/2008US7449585 1,2-dihydro-2-(4-trifluoromethylphenyl)-6-(3-trifluoromethyl-2-pyridinyl)-3H-indazol-3-one; capsaicin receptor ; analgesic, antiinflammatory, hypotensive agent; rheumatoid arthritis, osteoarthritis, headache, migraine, cancer and central nervous system pain, irritable bowel syndrome
11/11/2008US7449582 particularly tyrosine kinase, serine-threonine kinases, and MAP kinases; cancer, nervous system disorders and autoimmune diseases; 6-phenyl-7-oxo-7,8-dihydro-pyrido[2,3-d]pyrimidines, 3-phenyl-2-oxo-1,2-dihydro-[1,6]naphthyridines, and 3-phenyl-2-oxo-1,2-dihydroquinolines
11/11/2008US7449581 6-Substituted pyrido-pyrimidines
11/11/2008US7449578 substituted phenanthroline compounds with high two photon absorption cross sections; [3,8-Bis-{4-[2-(4-tert-butylsulfanyl-phenylvinyl]-phenyl}-[1,10] phenanthroline
11/11/2008US7449476 e.g. 2,3,4,5-tetrahydro-2-[2-[4-methoxy-7-(5-methyl-1H-1,2,4-triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]-1,2-dioxoethyl]-5-phenyl-1H-pyrido[4,3-b]indole; inhibit HIV entry by attaching to exterior viral envelop protein gp120 and interrupting viral entry process by interfering with cellular receptor CD4
11/11/2008US7449475 e.g. 2-{[(2S)-3-(5-Chloro-1'H,3H-spiro[1-benzofuran-2,4'-piperidin]-1'-yl)-2-hydroxypropyl]oxy}-N-cyclopropylbenzamide; macrophage inflammatory protein (MIP)-1 alpha chemokine receptor modulator; antiinflammatory, antiproliferative agent, autoimmune diseases
11/11/2008US7449473 8-(1-methyl-1H-pyrrol-2-yl)-1,3-dipropyl-1H-pyrrolo[3,2-d]pyrimidine-2,6-dione; asthma, chronic obstructive pulmonary disorder, emphysema, diabetic disorders, inflammatory gastrointestinal tract disorders, immunological/inflammatory disorders, cardiovascular diseases, neurological disorders
11/11/2008US7449472 Methods of inhibiting p38 with substituted bicyclic pyrimidines
11/11/2008US7449465 glycogen synthase kinase 3 alpha and 3 beta inhibitors; improved phanrmacological activity, potency, selectivity, solubility, permeability, metabolic stability; bipolar disorder; Alzheimer's disease; type II diabetes, neuropathic pain; depression; inflammatory diseases
11/11/2008US7449464 4-{3-[4-(6-Chlorobenzothiazol-2-yl)-1,4-diazepan-1-ylcarbonyl]benzyl}-1(2H)-phthalazinone; Cancer, BRCA deficient
11/11/2008US7449456 signal transducer and activator of transcription-6 inhibitors; asthma, COPD, respiratory, inflammatory and allergic diseases; compounds have less suppressive effect on immunological functions; 4-[(2,5 -difluorobenzyl) amino]-2-[(4-morpholin-4-ylphenyl)amino]pyrimidine-5 -carboxamide
11/11/2008US7449175 Delivery of erectile dysfunction drugs through an inhalation route
11/11/2008US7449174 Delivery of analgesics through an inhalation route
11/11/2008US7449172 Delivery of antiemetics through an inhalation route
11/06/2008WO2008134354A1 TNF-α PRODUCTION INHIBITOR
11/06/2008WO2008133669A2 Viral inhibitors
11/06/2008WO2008133274A1 Aminodihydrothiazine derivatives substituted with cyclic groups
11/06/2008WO2008133273A1 Pharmaceutical composition for treatment of alzheimer's disease
11/06/2008WO2008132454A1 Carbolines and their use as imaging agents
11/06/2008WO2008132211A1 Amino-quinazolinone derivatives for use as radiotracers and imaging agents
11/06/2008WO2008132162A1 3- (sulphonylamino) -phenyl-2 -hydroxy-ethylamino derivatives useful as beta-agonists, processes for preparing them and their use as medicaments
11/06/2008WO2008132121A1 Lh-indazole-3-amine compounds as ikk1 inhibitors
11/06/2008WO2008131922A1 New 4,8-diphenyl-polyazanaphthalene derivatives
11/06/2008WO2008104473A3 Pyrazolopyriidine derivatives and their use as kinase inhibitors
11/06/2008WO2008070358A3 N-cyclopropyl-hydroxyproline-based tripeptidic hepatitis c serine protease inhibitors containing an isoindole, pyrrolopyridine, pyrrolopyrimidine or pyrrolopyrazine heterocycle in the side chain
11/06/2008WO2008024977A3 Isoquinoline, quinazoline and phthalazine derivatives
11/06/2008US20080275235 Novel fused heteroaromatic compounds as transforming growth factor (tgf) inhibitors
11/06/2008US20080275090 P2Y1 Purinoreceptor; thromboembolic disorders; compounds are 2-((hetero)arylamino) benzimidazoles, benzoxazoles or benzothiazoles such as [2-(2-tert-butyl-phenoxy)-pyridin-3-yl]-(6-methyl-1H-benzoimidazol-2-yl)-amine
11/06/2008US20080275075 Medicine Comprising a Combination of an Acetylcholinesterase Inhibitor and a 5-Substituted-3-Oxadiazolyl-1,6-Naphthyridin-2(1H)-One Derivative
11/06/2008US20080275069 3,8-dimethyl-2-[4-(3-piperidin-1-ylpropoxy)phenyl]-4(3H)-quinazolinone; 6-chloro-3-methyl-2-[4-(3-piperidin-1-ylpropoxy)phenyl]pyrido[3,4-d]-pyrimidin-4(3H)-one; 2-[4-(1-cyclopentyl-4-piperidinyloxy)phenyl]-3-methylpyrido[2,3-d]-pyrimidin-4(3H)-one; treats metabolic, nervous system, vascular disorders
11/06/2008US20080275053 Heterocyclyl Compounds
11/06/2008US20080275052 Especially p38 MAP kinase alpha and beta; 2,4-difluorophenyl(3-(2-(trifluoromethyl)phenyl)-5,6-dihydroimidazo[1,5-a]pyrazin-7(8H)-yl)methanone
11/06/2008US20080275038 Imidazopyridine Derivatives as A2b Adenosine Receptor Antagonists
11/06/2008US20080275026 Benzamide derivatives as oxytocin agonists and vasopressin antagonists
11/06/2008US20080274462 Universal bases for nucleic acid analyses, methods for using universal bases, and kits comprising universal bases
11/06/2008CA2685247A1 New 4,8-diphenyl-polyazanaphthalene derivatives
11/06/2008CA2683887A1 Aminodihydrothiazine derivatives substituted with a cyclic group
11/06/2008CA2672298A1 Fused pyridine compounds useful in the prophylaxis or treatment of viral infections
11/05/2008EP1988077A1 Nirogenous heterocyclic derivatives substituted with cyclic groups
11/05/2008EP1987823A1 Condensation aerosol containing zaleplon for inhalation
11/05/2008EP1987034A1 Spiro condensed piperidnes as modulators of muscarinic receptors
11/05/2008EP1987033A1 Novel diazabicycloalkane derivatives and their medical use
11/05/2008EP1987032A1 3, 9-diazabicyclo(3.3.1)non-3-yl-aryl methanone derivatives as nicotinic acetylcholine receptor agonists
11/05/2008EP1987031A1 3-heteroaryl- 3,9-diazabicyclo[3.3.1]nonane derivatives as nicotinic acetylcholine receptor agonists
11/05/2008EP1987030A1 3 -deazapurine derivatives as tlr7 modulators
11/05/2008EP1987020A1 Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
11/05/2008EP1987010A1 Tricyclic n-heteroaryl-carboxamide derivatives containing a benzimidazole unit, method for preparing same and their therapeutic use
11/05/2008EP1987006A1 Novel aminoalcohol-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
11/05/2008EP1986645A1 Glucokinase activators
11/05/2008EP1638969B1 Cgrp receptor antagonists
11/05/2008EP1385514B1 Spiroindene and spiroindane compounds
11/05/2008EP1218383B1 Bicyclic imidazo-5-yl-amine derivatives
11/05/2008CN101300260A Method for synthesizing spiro quaternary ammonium systems
11/05/2008CN101300258A 5-OXO-5,8-dihydro-pyrido-pyrimidines as inhibitors of C-FMS kinase
11/05/2008CN101300257A Amide and carbamate derivatives of alkyl substituted N-[4-(4-amino-1H-imidazo[4,5-c]quinolin-1-yl)butyl]methanesulfonamides and methods
11/05/2008CN101300256A Crystalline salts of 7-[4-(4-naphthalen-1-yl-piperazin-1-yl)-but oxy]-3,4-dihydro-1H-[1,8]naphthyridin-2-one
11/05/2008CN101300255A Imidazolone phenylalanine derivatives as VLA-4 antagonists
11/05/2008CN101300254A Amide and carbamate derivatives of n-{2-[4-amino-2- (ethoxymethyl)-1h-imidazo[4,5-c]quinolin-1-yl]-1,1-dimethylethyl}methanesulfonamide and methods
11/05/2008CN101300248A Phosphonated fluoroquinolones, antibacterial analogs thereof, and methods for the prevention and treatment of bone and joint infections
11/05/2008CN101300247A 3-hydroxymethylbenzo[b]thiophene derivative and method for producing same
11/05/2008CN101300233A Azafused cyclin dependent kinase inhibitors
11/05/2008CN101298452A Preparing methods and uses of S-(-)-nadifloxacin and water soluble salt thereof
11/05/2008CN100430401C 4-phenyl substd. tetrahydroisoquinolines and therapeutic use thereof
11/05/2008CN100430398C Diazabicyclic central nervous systems active agents
11/05/2008CN100430395C Modified pictet-spengler reaction and products prepared therefrom
11/05/2008CN100430393C Pyran derivative
11/05/2008CN100430389C Inhibition of phsphoinostide 3-dinase beta
11/05/2008CN100430386C Phenylalanine derivatives as depeptidyl peptidase inhibitors for the treatment or prevention of diabetes
11/04/2008US7446199 Compositions useful as inhibitors of protein kinases
11/04/2008US7446166 Pyrrole units to allow chemical and electrochemical polymerization and a perylene diimide unit to absorb light so that the perylene diimide film can be produced by crosslinking via pyrrole moieties upon irradiating visible light; electrical, electronical and optical devices such as photo diodes
11/04/2008US7446113 the prodrug forms of compounds have good absorption, pharmacokinetics, distribution and transport to the brain; 4-[8-Trifluoromethyl-6-(4-trifluoromethyl-phenyl)-imidazo[1,2-a]pyridin-3-ylethynyl]-benzenesulfonamide; nervous system disorders like psychosis, schizophrenia, Alzheimer's disease, depression
1 ... 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 ... 646